Featured series 
Tag: HIV/AIDS
-
Nation & World
Plea from 1980s New York: ‘Please Stay Home’
Darrel Ellis exhibition at Carpenter Center looks back yet feels of the moment with its themes of family history, identity, loss.
-
Nation & World
‘When you see death all the time, you go into this mode of increased energy and sharper focus’
Pioneering AIDS researcher Myron “Max” Essex was one of the first to propose that a retrovirus was the cause of AIDS.
-
Nation & World
Ending HIV transmission by 2030
Eradicating the remaining pockets of HIV transmission in the U.S. by 2030 will be a challenge for the Trump administration, and depend on local cooperation in reaching high-risk groups with surveillance, prevention, and treatment, according to Harvard HIV/AIDS researcher Max Essex.
-
Nation & World
Making bone marrow transplants safer
Harvard Stem Cell Institute scientists have taken the first steps toward developing a treatment that would make bone marrow-blood stem cell transplantation safer.
-
Nation & World
Harvard licenses genotyping platform
Harvard University has granted a license to Aldatu Biosciences Inc., an early-stage diagnostics development company, for a novel genotyping platform that may help clinicians treating HIV to determine more quickly the most effective medication for each patient.
-
Nation & World
A promising strategy against HIV
Harvard Stem Cell Institute researchers at Massachusetts General and Boston Children’s hospitals for the first time have used a relatively new gene-editing technique to create what could prove to be an effective technique for blocking HIV from invading and destroying patients’ immune systems.
-
Nation & World
Viral load as an anti-AIDS hammer
Harvard researchers have joined with counterparts in the U.S. and Botswana governments to conduct a major evaluation of AIDS treatment targeted specifically to reduce infectivity.
-
Nation & World
Toward an AIDS-free generation
AIDS researchers and medical ethicists gathered at the Harvard School of Public Health to explore possible ethical issues affecting studies of promising strategies to fight the ailment.
-
Nation & World
Worldwide, women’s inequality
A U.N. official said Thursday that the world has made progress in reducing poverty and in meeting some of its eight Millennium Development Goals, but that entrenched inequality of women will slow efforts to meet equality and maternal mortality targets by 2015.
-
Nation & World
In Africa, success against AIDS
AIDS researchers gathered at the Harvard School of Public Health to mark 10 years of work under a landmark federal anti-AIDS program that has led to significant progress against the epidemic.
-
Nation & World
When parasites catch viruses
Researchers have found that a protozoan parasite causing an STD that affects a quarter of a million people yearly is fueled in part by its own viral symbiont. Antibiotics that simply kill the parasite are not the solution.
-
Nation & World
Triumphs against smallpox, polio, AIDS
Harvard researchers have been at the forefront of many battles against devastating diseases, leading pivotal breakthroughs against scourges from 1800 to the present.
-
Nation & World
Plotting the demise of AIDS
Hundreds of scientists, activists, doctors, and others who have been on the front lines battling the HIV virus, gathered on Harvard’s Longwood campus for a conference reflecting on progress against the ailment, while rededicating themselves to end the epidemic.
-
Nation & World
Tanzania-HSPH AIDS clinic opens
U.S. and Tanzanian government officials opened a new research and treatment center for Tanzania’s sickest AIDS patients Friday (July 22), to be operated by Tanzanian health officials in partnership with the Harvard School of Public Health.
-
Nation & World
A focus on battling tuberculosis
Scientists from around New England gathered at the Broad Institute of MIT and Harvard to discuss the latest research and findings about tuberculosis at the Fifth Annual New England Tuberculosis Symposium.
-
Nation & World
Accompanying the underserved
“The road from policy development to implementation is usually long and rocky, one that must be trod with companions,” Paul Farmer, University Professor and co-founder of Partners In Health, told Harvard Kennedy School graduates on May 25.
-
Nation & World
One vaccine for two strains?
Harvard Medical School researchers believe that identifying the properties of the herpes viruses found in Africa could open the door to developing a more potent vaccine against an infection now rampant in sub-Saharan Africa.
-
Nation & World
The improbable appears promising
A section of the AIDS virus’ protein envelope once considered an improbable target for a vaccine now appears to be one of the most promising, new research by Harvard-affiliated Dana-Farber Cancer Institute scientists indicates.
-
Nation & World
Protein that helps battle HIV
Harvard researchers at Massachusetts General Hospital and the Ragon Institute of MGH, MIT and Harvard find that elevated levels of p21, a protein best known as a cancer fighter, may be involved in the immune system’s ability to control HIV infection.
-
Nation & World
Lesotho: MDRTB Outpatients
The tiny African nation of Lesotho is among those hardest hit by the raging twin epidemics of ADIS and tuberculosis. Harvard faculty members are advising the government and helping to revamp clinics and treat patients in the far-flung mountain regions of this poor country.
-
Nation & World
Congo: Survivors Song
Researchers from the Harvard Humanitarian Initiative have been working in the Democratic Republic of the Congo for several years examining the roots of the violence against women that has plagued this war-torn region.
-
Nation & World
South Africa: Durban Labs
One of the continent’s richest nations, South Africa also has one of the world’s highest HIV infection rates and is home to the world’s biggest population of HIV-infected people, an estimated 5.5 million.
-
Nation & World
Lesotho: She looks better
The tiny African nation of Lesotho is among those hardest hit by the raging twin epidemics of AIDS and tuberculosis. Harvard faculty members are advising the government and helping to revamp clinics and treat patients in the far-flung mountain regions of this poor country.
-
Nation & World
Botswana: One Woman’s Story
Though there are signs that the Botswana AIDS epidemic is slowing, the disease remains the top cause of death in the southern African nation. HIV infection rates are down nationwide to 24 percent, while life expectancy, which had fallen from 64 in 1990 to 40, rose to 50 in 1997.
-
Nation & World
South Africa: Valley of 1,000 Hills
One of the continent’s richest nations, South Africa also has one of the world’s highest HIV infection rates and is home to the world’s biggest population of HIV-infected people, an estimated 5.5 million.
-
Nation & World
Lesotho: The Pilots
The tiny African nation of Lesotho is among those hardest hit by the raging twin epidemics of ADIS and tuberculosis. Harvard faculty members are advising the government and helping to revamp clinics and treat patients in the far-flung mountain regions of this poor country.
-
Nation & World
Keeping HIV out of the cradle
A Harvard School of Public Health AIDS Initiative trial that gave HIV-positive mothers in Botswana antiretroviral drugs during the months after birth showed a dramatic reduction in the transmission of the virus from mothers to breast-fed babies.
-
Nation & World
Partnerships, training key to global health
Partnerships, training of local medical personnel, and practice in delivering services are all key if the effort to improve global health is to be successful, say speakers at the Massachusetts General Hospital Center for Global Health’s inaugural symposium.
-
Nation & World
Hope for AIDS vaccine?
Progress on several fronts has raised optimism about the possibility of achieving an effective AIDS vaccine in the coming years, a speaker at the Harvard School of Public Health said Tuesday (Nov. 9).
-
Nation & World
The rise of chronic disease
Heart disease, diabetes, and other chronic diseases are becoming enormous problems in the developing world and need more attention even as the challenge of fighting infectious diseases like AIDS shows no sign of abating, according to Institute of Medicine President Harvey Fineberg.
